Prot #GS-US-337-0123: A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Pos

Project: Research project

Project Details

StatusFinished
Effective start/end date9/20/139/20/16

Funding

  • Quintiles, Inc. (Prot #GS-US-337-0123)
  • Gilead Sciences, Inc. (Prot #GS-US-337-0123)